Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026)
Lantheus Holdings (LNTH) reported Other Operating Expenses of $59.3 million for Q1 2026, up 288.7% quarter-over-quarter from $15.3 million in Q1 2021.
Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 5 years of Other Operating Expenses data on file, last reported at $59.3 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $59.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $59.3 million (changed N/A YoY), and the FY2020 annual result was $40.9 million, down 2.36% from the prior year.
- Other Operating Expenses grew to $59.3 million in Q1 2026 per LNTH's latest filing, from $15.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $59.3 million in Q1 2026 and troughed at $59.3 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.33 Mn |
| Mar 31, 2021 | 15.26 Mn |
| Dec 31, 2016 | -120,000.00 |
| Sep 30, 2016 | 560,000.00 |
| Jun 30, 2016 | 117,000.00 |
| Mar 31, 2016 | 5.83 Mn |
| Dec 31, 2015 | 7.81 Mn |
| Sep 30, 2015 | 8.63 Mn |
| Jun 30, 2015 | 9.23 Mn |
| Mar 31, 2015 | 9.07 Mn |
| Dec 31, 2014 | 7.89 Mn |
| Sep 30, 2014 | 8.33 Mn |
| Jun 30, 2014 | 9.40 Mn |